Crop Biotech Update

Report Projects the Future of CRISPR-Cas Market

February 15, 2023

The global CRISPR-Cas gene editing market is valued at ~US$ 830.7 Mn in 2022 and is projected to achieve a compound annual growth rate of 22.8% from 2023 to 2030. This forecast is according to the report released by Coherent Market Insights.

CRISPR, an abbreviation for clustered regularly interspaced short palindromic repeats, is a simple but powerful tool for editing genomes. It enables researchers to easily modify DNA sequences and change their function. It has numerous applications in healthcare, food, and agriculture. The other similar gene editing techniques include ZFNs (Zinc Finger Nucleases) and TALENs (Transcription Activator-Like Effector Nucleases).

The report enumerated the prominent and emerging players in the market, which include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc. It also presents the profitable segments/subsegments for the market, which may affect the global expansion strategy of leading organizations.

Read more from Digital Journal.

You might also like: